Hackensack Meridian CDI has Struck a COVID-19 Research Collaboration with Merck
July 14, 2020
The collaborative work aims to find drugs to treat the pandemic
The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with Merck to investigate drugs for treating COVID-19.
The CDI will work with Merck to identify candidate treatments for the still-spreading pandemic.